Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Rat NMDAR1 ELISA Kit (AC3590)
Cat.#: ASET-2179
Specifications
Description Rat NMDAR1 ELISA Kit allows for the in vitro quantitative determination of rat NMDAR1 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Rat Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.094 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.156-10 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1929 Human APH1A ELISA Kit (AC3340) Quantitative inquiry ASET-1972 Human Progranulin ELISA Kit (AC3383) Quantitative inquiry ASET-1169 Human CELSR2 ELISA Kit (AC2580) Quantitative inquiry ASET-1258 Human PCDH1 ELISA Kit (AC2669) Quantitative inquiry ASET-1285 Human Serotonin Transporter ELISA Kit (AC2696) Quantitative inquiry ASET-2482 Mouse ApoER2 ELISA Kit (AC3893) Quantitative inquiry ASET-2404 Porcine TSH ELISA Kit (AC3815) Quantitative inquiry ASET-1603 Human KCNQ1 ELISA Kit (AC3014) Quantitative inquiry ASET-2151 Mouse Adenosine A1 Receptor ELISA Kit (AC3562) Quantitative inquiry ASET-2528 Human Neuropeptide S ELISA Kit (AC3939) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket